January 16, 2024- A meaningful contributor to Abbott’s resilience during the pandemic is its diverse business model. Featuring a market-leading portfolio, iterative products, a balanced customer mix, and global footprint, Abbott has created long-term value for shareholders, according to Abbott’s Chairman and CEO Robert Ford at the recent 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. Additional insights presented at the conference included the achievement of double-digit sales growth, the company’s FreeStyle Libre continuous glucose monitors, and its portfolio of cardiovascular devices.